MedTrace Logo

Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product

NCT05300984 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2023-04-06

No results posted yet for this study

Summary

The aim of this study is to investigate the effect of cosmetic products with two different concentrations of the active on skin aging and in acting on the mitochondrial health of skin in comparison to a placebo product.

Conditions

  • Skin Aging

Interventions

OTHER

Topical Placebo Cream

cosmetic cream to be applied topically on face and forearms twice/daily using split/face design

OTHER

Topical Cream with 0.5% Active

cosmetic cream to be applied topically on face and forearms twice/daily using split/face design

OTHER

Topical Cream with 1% Active

cosmetic cream to be applied topically on face and forearms twice/daily using split/face design

Sponsors & Collaborators

  • proDERM GmbH

    collaborator INDUSTRY

  • Amazentis SA

    lead INDUSTRY

Principal Investigators

  • Prof. Dr. med. Klaus-Peter Wilhelm, Dermatologist, MD · proDERM GmbH

  • Dr. rer. nat. Sabrina Laing, MD · proDERM GmbH

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-15
Primary Completion
2022-05-10
Completion
2022-05-16

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05300984 on ClinicalTrials.gov